What is the appropriate management of a bleeding scalp wound in a patient who is not taking any antiplatelet or anticoagulant medications?

Management of Bleeding Scalp Wound in Patient Not on Anticoagulants or Antiplatelets

For a bleeding scalp wound in a patient not taking anticoagulants or antiplatelets, apply direct manual compression with gauze for 3-5 minutes as first-line management, and if bleeding persists, apply topical hemostatic agents such as thrombin with absorbable gelatin sponge or oxidized cellulose (Surgicel) directly to the wound bed. 1, 2

Initial Assessment and Classification

Determine bleeding severity immediately by assessing for the following criteria 1:

• Hemodynamic instability (hypotension, tachycardia, altered mental status)
• Hemoglobin decrease ≥2 g/dL from baseline
• Need for ≥2 units of RBC transfusion
• Active bleeding that cannot be controlled with simple pressure after 15-20 minutes 3

If none of these factors are present, the bleeding is considered non-major and can be managed with local measures alone 1, 2.

Management of Non-Major Scalp Bleeding

Primary Local Hemostatic Measures

Apply direct manual compression as the cornerstone of management 1, 2:

• Clean the wound with sterile saline 2
• Apply clean gauze directly to the bleeding site with gentle manual compression for 3-5 minutes 3, 2
• Maintain consistent pressure without repeatedly lifting the gauze to check for bleeding 2

Topical Hemostatic Agents if Initial Compression Fails

If bleeding persists after initial compression, apply topical hemostatic agents 2, 4:

• Thrombin (RECOTHROM) at 1,000 units/mL applied with absorbable gelatin sponge achieves hemostasis in 95% of patients within 10 minutes 4
• Oxidized cellulose (Surgicel) applied directly to the wound bed with gentle pressure for 3-5 minutes, then secured with non-adherent dressing 2
• Multiple layers of hemostatic agents can be applied if single application fails 2

Wound Closure and Dressing

After achieving hemostasis 2:

• Cover with non-adherent dressing to prevent disruption of clot formation
• Change dressing every 24-48 hours and monitor for recurrent bleeding
• Consider sutures or staples for scalp lacerations once hemostasis is achieved

Management of Major Scalp Bleeding

If the patient meets criteria for major bleeding, escalate management immediately 1:

• Provide volume resuscitation with IV crystalloids 3
• Apply aggressive local therapy including multiple layers of hemostatic agents 2
• Consider surgical intervention if bleeding persists despite local measures, including ligation of bleeding vessels or surgical debridement 1, 3
• Transfuse RBCs to maintain hemoglobin ≥7 g/dL (or ≥8 g/dL if coronary artery disease present) 5

Assessment for Contributing Factors

Evaluate for comorbidities that could contribute to bleeding 1:

• Thrombocytopenia (check platelet count; transfuse if <50,000/μL in active bleeding) 5
• Uremia (assess renal function; consider desmopressin if uremic platelet dysfunction suspected) 1
• Liver disease (check coagulation studies; consider hematology consultation) 1, 5
• Hypothermia and acidosis (correct these as they worsen coagulopathy) 5

Common Pitfalls to Avoid

Do not repeatedly lift the gauze to check for bleeding during the initial 3-5 minute compression period, as this disrupts clot formation 2.

Do not use thrombin concentrations >1,000 units/mL, as higher concentrations provide no additional benefit over 1,000 units/mL 4.

Do not delay surgical consultation if bleeding persists after 15-20 minutes of appropriate local measures, as this indicates need for procedural intervention 3.

Monitoring After Hemostasis

Once bleeding is controlled, monitor closely for 2, 5:

• Recurrent bleeding at the wound site
• Signs of infection (erythema, warmth, purulent drainage)
• Proper wound healing and absorption of hemostatic materials
• Serial hemoglobin levels if significant blood loss occurred